Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
Publication
, Other
Published in: J Clin Oncol
February 20, 2012
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 20, 2012
Volume
30
Issue
6
Start / End Page
678
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. (2012). J Clin Oncol. United States. https://doi.org/10.1200/jco.2012.42.0331
“Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.” J Clin Oncol, February 20, 2012. https://doi.org/10.1200/jco.2012.42.0331.
Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. Vol. 30, J Clin Oncol. 2012. p. 678.
“Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.” J Clin Oncol, vol. 30, no. 6, 20 Feb. 2012, p. 678. Pubmed, doi:10.1200/jco.2012.42.0331.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 20, 2012
Volume
30
Issue
6
Start / End Page
678
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences